Valisure Researchers Highlight Zantac Health Risks

  • Zantac-Medical-Record-Review-&-Outsourcing-Services-1

Last month, Valisure researchers highlighted serious health risks inherent in Zantac through two new independent studies published in JAMA Network Open and MedRxiv.

In these studies, the online pharmacy established that under simulated gastric conditions the active ingredient ranitidine easily converts to cancer-causing chemicals N-nitrosodimethylamine (NDMA). The new findings also suggest that the formation of NDMA is an inherent Zantac risk, which exposes the user to the known carcinogen released inside the body.

According to the research published in the JAMA Network Open, the pharmacy evaluated the conditions that stimulated ranitidine NDMA production by imitating gastric processes. The researchers noted that after two hours a 150 mg tablet of cool mint Zantac converted into 947 nanograms (ng) of NDMA, a limit 10 times higher than the FDA’s daily acceptable limit of 96 ng of NDMA consumption. The research also revealed that an increase in nitrate concentrations increased the limit to 320,000 ng.

The research published in MedRxiv was the result of a study on more than 10,000 cancer patients, which showed a strong association between users of Zantac and an increased risk of breast cancer, thyroid cancer, bladder cancer, and prostate cancer as compared to the users who consumed heartburn drugs that did not contain ranitidine.

Zantac lawsuits are growing in numbers, and it currently comprises approximately 1,000 lawsuits. The litigation is presided by Judge Robin L. Rosenberg of the U.S. District Court for the Southern District of Florida.

The lawsuits allege Pfizer Inc., Sanofi SA, Boehringer Ingelheim Pharmaceuticals Inc., and GlaxoSmithKline LLC, along with generics makers, distributors, pharmacies, and others in the supply chain, of misleading advertising, failure to warn, and other claims associated with the presence of cancer-causing chemical NDMA in the popular heartburn drug.

We are social:

Accreditations

NSIC - CRISIL

NSIC-CRISIL has assigned a "SE 2A" rating to Neural IT, indicating a company with High Performanc...

ISO 27001 Certification

Neural IT is officially ISO 27001:2013 (ISO 27001) certified by Alcumus ISOQAR Limited as the Cer...

HIPAA

Neural IT has successfully implemented HIPAA for securing Health records....

Associations

NYSTLA

NYSTLA - "Neural IT is proud to be associated with NYSTLA (New York State Trial Lawyers Associati...

CAOC

CAOC - "Neural IT is proud to be associated with CAOC (Consumer Attorneys of California) as a Ven...

CAALA

CAALA - "Neural IT is proud to be associated with CAALA (Consumer Attorneys Association of Los An...

News & Events

Friends Of CAALA 2020
It is a treasured moment for Neural IT to be associated as an Affiliate Member for so many years and receive an…
sharing-smiles-sharing-happiness-on-national-smile-day-event-neural-it
Amidst the chaos of COVID-19 pandemic, we have something to cheer about as today is National Smile Day, and a smile is…
Happy Mother's Day from Neural IT
The cagey pandemic has halted our lives, but the only spirits that kept igniting during the crisis are the ones whom we…

Latest Tweets